Pfizer (NYSE: PFE) Stock Climbs on Q1 Earnings Beat, Non-COVID Product Sales Drive Growth
Pfizer (NYSE: PFE) stock jumped 6% in intraday trading Wednesday following the release of its first-quarter earnings report. Investors reacted […]
Pfizer
Pfizer (NYSE: PFE) Stock Surges on Upbeat Commentary from Ritholtz Wealth Management CEO
Pfizer (NYSE: PFE) stock rebounded from their 11-year low on Wednesday following bullish remarks from the CEO of Ritholtz Wealth
Pfizer (NYSE: PFE) Stock Surges on Upbeat Commentary from Ritholtz Wealth Management CEO Read More »
Pfizer (NYSE: PFE) Stock Drops on Mixed Q4 Earnings
Pfizer (NYSE: PFE) stock declined almost 2% on Tuesday after its ReutersQ4 earnings report revealed a mix of results, with
Pfizer (NYSE: PFE) Stock Drops on Mixed Q4 Earnings Read More »
Pfizer (NYSE: PFE) Stock Drops Despite Positive Regulatory News on Hemophilia B Gene Therapy
Pfizer (NYSE: PFE) stock fell more than 2% on Thursday, even though Canadian regulators approved its Gene Therapy for Hemophilia
Churchill Management Corp Cuts Stake in Pfizer (PFE) by 90.6% in Q1: SEC Filing
In a recent disclosure with the Securities & Exchange Commission, it has been revealed that Churchill Management Corp, a notable
Churchill Management Corp Cuts Stake in Pfizer (PFE) by 90.6% in Q1: SEC Filing Read More »
Pfizer (PFE) Shares Plummet Over 5% Today, But Why?
Pfizer Inc. (NYSE: PFE) announced today that it is discontinuing the development of its once-a-day experimental obesity pill due to
Pfizer (PFE) Shares Plummet Over 5% Today, But Why? Read More »
Pfizer Inc. (NYSE: PFE) Resilience Surprises Investors Amidst Market Downturn
Shares of Pfizer Inc. (NYSE: PFE) experienced a notable increase of 2.24% on Wednesday, with moderate trading volume. This surge
Pfizer Inc. (NYSE: PFE) Resilience Surprises Investors Amidst Market Downturn Read More »
